Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) has been given an average rating of “Moderate Buy” by the six brokerages that are presently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among […]